Press Releases
Amidst large investment from parent company, Samsung Biologics seeks to ramp up biotech funding
MEDIA FOCUS
Amidst Large Investment From Parent Company, Samsung Biologics Seeks to Ramp Up Biotech Funding
John Rim
President & CEO
During BIO 2022 in San Diego, John Rim, CEO and President of Samsung Biologics, discussed the company’s future investments as part of its roadmap for sustainable growth with Endpoints News.
MEDIA FOCUS
Amidst Large Investment From Parent Company, Samsung Biologics Seeks to Ramp Up Biotech Funding
John Rim
President & CEO
During BIO 2022 in San Diego, John Rim, CEO and President of Samsung Biologics, discussed the company’s future investments as part of its roadmap for sustainable growth with Endpoints News.